All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
Treatment sequencing for anemic myelofibrosis
with Jean-Jacques Kiladjian & Angela Fleischman
Monday, February 26, 2024 | 16:30 CET
This independent educational activity is supported by Bristol Myers Squibb. All content is developed independently by the faculty. The funder is allowed no influence on the content of this activity.
Erythropoiesis-stimulating agents stimulate the bone marrow’s proliferation and differentiation of red blood cell progenitors, while simultaneously preventing apoptosis of red blood cells. They are used for management of anemia, a condition common amongst cancer patients.
Save to your areas of interest